61 related articles for article (PubMed ID: 3742481)
1. Nature of the binding of activated cyclophosphamide to calf thymus DNA and pBR-322 plasmid DNA.
Bansal SK; Love JH; Faletto MB; Gurtoo HL; Struck RF
Cancer Biochem Biophys; 1986 Jul; 8(3):193-202. PubMed ID: 3742481
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
[TBL] [Abstract][Full Text] [Related]
3. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
Ross MK; Pegram RA
Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
[TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressant effect of cyclophosphamide activated in vitro by liver microsomes from different strains of mice].
Telegin LIu; Zhirnov GF; Mazurov AV; Pevnitskiĭ LA
Biull Eksp Biol Med; 1981 Jul; 92(7):57-60. PubMed ID: 7295946
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA.
Frederick CB; Mays JB; Ziegler DM; Guengerich FP; Kadlubar FF
Cancer Res; 1982 Jul; 42(7):2671-7. PubMed ID: 7083159
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of N-hydroxylation of 3-amino-1-methyl-5H-pyrido[4,3-b]indole by cytochrome P-450 in the covalent binding to DNA.
Mita S; Ishii K; Yamazoe Y; Kamataki T; Kato R; Sugimura T
Cancer Res; 1981 Sep; 41(9 Pt 1):3610-4. PubMed ID: 7020934
[TBL] [Abstract][Full Text] [Related]
8. Studies on the binding of [3H-chloroethyl]-cyclophosphamide and 14[C-4] -cyclophosphamide to hepatic microsomes and native calf thymus DNA.
Gurtoo HL; Dahms R; Hipkens J; Vaught JB
Life Sci; 1978 Jan; 22(1):45-52. PubMed ID: 625188
[No Abstract] [Full Text] [Related]
9. Interaction of cyclophosphamide with DNA in isolated rat liver cell nuclei.
Lindemann H
Anticancer Res; 1984; 4(1-2):53-8. PubMed ID: 6712177
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.
Chang TK; Weber GF; Crespi CL; Waxman DJ
Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617
[TBL] [Abstract][Full Text] [Related]
11. Roles of 2-haloethylene oxides and 2-haloacetaldehydes derived from vinyl bromide and vinyl chloride in irreversible binding to protein and DNA.
Guengerich FP; Mason PS; Stott WT; Fox TR; Watanabe PG
Cancer Res; 1981 Nov; 41(11 Pt 1):4391-8. PubMed ID: 7030476
[TBL] [Abstract][Full Text] [Related]
12. Evidence for peroxidase-mediated metabolism of cyclophosphamide.
Kanekal S; Kehrer JP
Drug Metab Dispos; 1993; 21(1):37-42. PubMed ID: 8095224
[TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of model pyrroles by cytochrome P-450.
Guengerich FP; Mitchell MB
Drug Metab Dispos; 1980; 8(1):34-8. PubMed ID: 6102027
[TBL] [Abstract][Full Text] [Related]
14. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
Hemminki K
Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
[TBL] [Abstract][Full Text] [Related]
15. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
Hales BF
Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
[TBL] [Abstract][Full Text] [Related]
16. [In vivo studies on the transformation of cyclophosphamide to mutagenic metabolites].
Della Morte R; Belisario MA; Farina C; Martire G; Staiano N; De Lorenzo F
Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1061-7. PubMed ID: 7138675
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450.
Miller RE; Guengerich FP
Cancer Res; 1983 Mar; 43(3):1145-52. PubMed ID: 6825087
[TBL] [Abstract][Full Text] [Related]
19. Trapping of DNA-reactive metabolites of therapeutic or carcinogenic agents by carbon-14-labeled synthetic polynucleotides.
Mehta JR; Ludlum DB
Cancer Res; 1982 Aug; 42(8):2996-9. PubMed ID: 7093949
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.
Gurtoo HL; Marinello AJ; Struck RF; Paul B; Dahms RP
J Biol Chem; 1981 Nov; 256(22):11691-701. PubMed ID: 7298626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
